Do Berberine Patches Work? What the Evidence Shows

No human study has measured whether berberine from a patch gets through the skin, so nobody can say a berberine patch works. One 2018 rat study tested laboratory-made transdermal formulations, not a retail patch, and no patch on sale has published how much berberine it contains, how much it releases or what reaches the blood. Swallowed berberine has the evidence: mostly at 900 to 2,400 mg a day, it lowered HbA1c by about 0.6 percentage points over about three months in people with type 2 diabetes and body weight by about 0.9 to 2 kg in adults with metabolic conditions, and a patch would have to deliver comparable exposure to borrow those results.^{1, 2, 3, 14}

Sources checked on 30 October 2026.

• Evidence: no human absorption or outcome study of any berberine patch
• Chemistry: berberine carries a permanent positive charge, the kind of molecule skin is built to keep out
• Safety: the interactions and the pregnancy warning apply to any berberine that is absorbed, and a patch gives you no dose to tell a pharmacist

What is a berberine patch supposed to do?

Berberine patches are sold for weight loss, often with the GLP-1 name attached, to people who cannot get or no longer want the injections. Most are blends. A 2026 review in a US pharmacy journal identified 24 transdermal patch products and one gel marketed this way, averaging seven plant ingredients each; berberine, glutamine, cinnamon and pomegranate were the most common. None posted a certificate of analysis, many used misleading advertising, and several carried reviews describing no effect or adverse events.⁴ The claim is that berberine's effects on blood sugar and weight, which come from oral trials, will transfer to a few milligrams released through the skin over a day.

Has anyone tested whether berberine gets through skin?

In people, no. In the laboratory, a few times, all with laboratory formulations. A 2018 study developed its own transdermal formulations of berberine and of dihydroberberine, a reduced form, and compared them with oral berberine in rats; the transdermal preparations produced higher blood levels than swallowing did, over eight hours and over fourteen days.⁵ Three things stop that answering the question. The formulations were made in a laboratory and are not what is in any retail patch; the study was in rats, not people; and higher than oral is a low bar, because very little swallowed berberine reaches the blood at all, under 1% in animal studies and low nanogram-per-millilitre concentrations in people.^{1, 6} The skin-delivery literature explains why patches are hard: berberine is a quaternary alkaloid with a permanent positive charge, and charged molecules do not cross intact skin well, so researchers use microneedles, which physically breach the outer layer, or pair berberine with a fatty acid to mask the charge.^{7, 8} A flat adhesive patch does neither.

What would a patch need to show?

The same four things as any form. Content: how many milligrams of berberine are in the patch. Release: how much leaves it over the wear time. Absorption: blood levels in people, compared with the oral doses the trials used. Outcome: HbA1c, glucose, cholesterol or weight over at least twelve weeks against a placebo patch. Oral berberine has all four for glucose and lipids, mostly at 900 to 2,400 mg a day in people with type 2 diabetes;² the berberine guide sets those trials out. A patch has published none.

Where do people put berberine patches?

Where the instructions say: usually clean, dry, hairless skin on the upper arm, shoulder, abdomen or thigh, changed daily and moved to a new site each time. Those directions are copied from licensed medicine patches; for berberine there is no absorption study at any site, so none can be called better. Rotating the spot is still right: the adhesive is the one component with a known effect. If a patch causes itching, blistering or a spreading rash, take it off.

Are berberine patches safe, and do they interact with medicines?

If any berberine is absorbed, yes, in the same ways as a capsule, and a patch makes the problem worse by hiding the dose. Swallowed berberine raised blood levels of the transplant medicine ciclosporin by about 29% in kidney-transplant patients, and two weeks at 900 mg a day reduced the activity of the CYP3A4, CYP2D6 and CYP2C9 enzymes that clear many antidepressants, anticoagulants, statins and blood-pressure medicines; it also lowers glucose, which matters to anyone on gliclazide, glimepiride, insulin or a GLP-1 injection.^{9, 10} Those effects depend on how much berberine reaches the liver and gut, and nobody knows what a patch delivers. Berberine displaces bilirubin from its carrier protein, which is why it is avoided in pregnancy, breastfeeding and infancy: in a jaundiced newborn the freed bilirubin can damage the brain; the French food-safety agency's 2019 opinion also advises children, adolescents and people with diabetes or liver or heart conditions not to take berberine supplements, and a patch does not change who those warnings are for.^{11, 18} What medicines interact with berberine goes through the medicines one by one.

What about moringa patches, and berberine versus moringa?

Moringa, the leaf powder from the drumstick tree, turns up in the same blended patches and in "moringa and berberine" products. We found no clinical trial of any moringa patch, so "berberine or moringa for weight loss" has no trial on either side in patch form. The side effects of a moringa-and-berberine patch are the ones any patch can have: skin irritation, and whatever any absorbed compound does.

Do weight-loss patches work on the NHS?

The NHS does not offer or recommend any weight-loss patch. Its overweight and obesity page sets out what a GP can offer: advice and referral for weight management programmes, medicines or surgery.^{12, 13} "Is there any weight-loss patch that works" has the same answer: no patch sold as a supplement has published an outcome trial. Can you take berberine with or after Mounjaro and do GLP-1 supplements work cover the oral options.

If you want berberine, which form has the trials?

Capsules and tablets, swallowed with meals. Every glucose, cholesterol and weight trial used oral berberine, mostly 900 mg a day or more, for about three months.^{2, 3} UK products range from a few hundred milligrams a day up to the full trial dose, and how to take berberine explains the label, timing and the gut effects the trials recorded. Does berberine work for weight loss has the weight figures beside the injections'.

What are GLP-1 patches?

Stick-on patches sold as "GLP-1 patches" or "GLP-1 support": the same plant blends as the berberine patches above, sometimes worded as if the medicine came through the skin.⁴ It does not. The GLP-1 medicines are peptides many times larger than the roughly 500-dalton limit for crossing intact skin; no absorption of GLP-1 or any similar peptide through intact human skin has been shown.¹⁵ The medicines that act on the GLP-1 receptor are tirzepatide (Mounjaro), semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), given by injection, plus a daily semaglutide tablet for type 2 diabetes, all on prescription.^{13, 16} A patch with GLP-1 on the box is a plant-extract patch.

What we don't know

No human study has measured berberine absorption from any patch and no patch has an outcome trial.⁴ The one animal study came from a company with a patent pending on its formulation.⁵ Berberine's safe intake is unsettled: EFSA's opinion on berberine plant preparations was still a draft out for consultation in 2026, and national limits differ more than tenfold.^{6, 17}

Frequently asked questions

Do those berberine patches really work?

Nobody knows, because no human study has measured absorption from a berberine patch and no patch has an outcome trial. The transdermal studies were laboratory studies of laboratory formulations, none in people.^{5, 7, 8}

Can berberine patches help weight loss?

Oral berberine's trials show about 0.9 to 2 kg in adults with metabolic conditions; a patch has no data showing it delivers any berberine, so those figures cannot be assumed for it.^{3, 14}

Is any berberine patch better than another?

We do not rank products, and no patch has published content, release, absorption or outcome data to rank on.

Sources

1. Liu CS, et al. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia, 2016. Narrative review. PubMed 26851175.
2. Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes. Frontiers in Pharmacology, 2022. Meta-analysis, 37 randomised trials, 3,048 adults with type 2 diabetes; no conflicts declared. PubMed 36467075.
3. Elahi Vahed I, et al. The effect of berberine on obesity indices. International Journal of Obesity, 2026. Meta-analysis, 23 randomised trials in adults; no competing interests declared. PubMed 41310257.
4. White CM. Transdermal "natural GLP‑1" dietary supplements violate law and place patients at risk. Annals of Pharmacotherapy, 2026. Market survey, 25 US products; no conflicts declared. PubMed 41480958.
5. Buchanan B, et al. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine. PLoS One, 2018. Rat study; authors employed by the company holding the pending patent. PubMed 29579096.
6. Dumitru CN, et al. Berberine-drug interactions. Pharmaceuticals, 2026. Narrative review; no conflicts declared. PubMed 42653808.
7. Cui X, et al. Visualizing the transdermal delivery of berberine loaded within chitosan microneedles. Analytical and Bioanalytical Chemistry, 2024. Laboratory skin study; no competing interests declared. PubMed 39400576.
8. Torky AS, et al. Novel skin penetrating berberine oleate complex. International Journal of Pharmaceutics, 2018. Laboratory and rat study; funding not stated on PubMed. PubMed 30053489.
9. Wu X, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients. European Journal of Clinical Pharmacology, 2005. Randomised trial, 104 kidney-transplant recipients, 3 months; funding not stated on PubMed. PubMed 16133554.
10. Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology, 2012. Randomised crossover, healthy men, 2 weeks; no conflicts declared. PubMed 21870106.
11. Chan E. Displacement of bilirubin from albumin by berberine. Biology of the Neonate, 1993. Laboratory and rat study. PubMed 8513024.
12. NHS. Overweight and obesity. nhs.uk/conditions/overweight-and-obesity. Read 30 October 2026; page last reviewed 11 October 2023 (review overdue).
13. NHS. Tirzepatide. nhs.uk/medicines/tirzepatide. Read 30 October 2026; page last reviewed 15 May 2026.
14. Asbaghi O, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes. Clinical Nutrition ESPEN, 2020. Meta-analysis, 12 randomised trials in adults with metabolic conditions; no conflicts declared. PubMed 32690176.
15. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology, 2000. Review. PubMed 10839713.
16. NHS. Semaglutide. nhs.uk/medicines/semaglutide. Read 30 October 2026; page last reviewed 15 May 2026.
17. EFSA NDA Panel. Draft scientific opinion on the safety of plant preparations containing berberine, endorsed 29 January 2026, public consultation 3 March to 11 May 2026. efsa.europa.eu. Read 30 October 2026.
18. ANSES. Opinion on the safety of berberine-containing plants in food supplements, saisine 2018-SA-0095. Agency opinion, 1 August 2019. anses.fr.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. If you take any regular medicine, ask a pharmacist before using a berberine product in any form.